Meeder Asset Management Inc Aquestive Therapeutics, Inc. Transaction History

Meeder Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 02, 2020	SELL	$4.12 - $9.09 $5,257 - $11,598	-1,276 Closed	0 $0
Q2 2020 Aug 11, 2020	SELL	$1.84 - $6.44 $4,309 - $15,082	-2,342 Reduced 64.73%	1,276 $6,000
Q1 2020 May 15, 2020	BUY	$1.54 - $6.75 $1,001 - $4,387	650 Added 21.9%	3,618 $8,000
Q4 2019 Feb 13, 2020	SELL	$3.06 - $8.78 $15,792 - $45,313	-5,161 Reduced 63.49%	2,968 $17,000
Q3 2019 Oct 17, 2019	BUY	$3.04 - $4.91 $20,301 - $32,788	6,678 Added 460.23%	8,129 $26,000
Q2 2019 Aug 05, 2019	SELL	$3.72 - $6.95 $159 - $298	-43 Reduced 2.88%	1,451 $6,000
Q1 2019 Apr 16, 2019	SELL	$5.74 - $8.05 $10,326 - $14,481	-1,799 Reduced 54.63%	1,494 $10,000
Q4 2018 Jan 17, 2019	BUY	$6.09 - $18.0 $20,054 - $59,274	3,293 New	3,293 $20,000

122

46.8M

517K

207K

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $243M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.